1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow IMC-001: new trials by email Literature Review of IMC-001 trials Research Report on IMC-001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome. IMC-001 and Optimal medical treatment, IMC-001 placebo and optimal medical treatment - Atherosclerosis | Early Phase 1 | Recruiting | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 18 | 2025-03-10 | 2026-04-15 |
Acute Coronary Syndrome (1) · Atherosclerosis (1)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1)
China (1)
Jun Pu, M.D. (1)